LEADING EDGE

A publication of the CCRN

The Leading Edge is a print and online publication developed by the Canadian Cardiovascular Research Network. Through the Leading Edge, CCRN hopes to update physicians and other health care professionals in the latest advances in cardiovascular medicine. By bringing together the opinions of expert researchers, clinicians, and communicators, CCRN hopes that the Leading Edge becomes a must-read in your clinical practice. Each issue also features a front-page column entitled 'The Bottom Line' which quickly conveys the most important learning points within that issue. We sincerely hope you enjoy the Leading Edge and we welcome your comments and feedback, which can be sent to info@ccrnmd.com.

Milan Gupta, MD, Subodh Verma, MD
Editors




Should HDL be a therapeutic target?

Date: December 09, 2011
Faculty: Dr. Robert Hegele, Dr. Lawrence Leiter, Dr. Jaques Genest

The role of high-density lipoprotein (HDL) in cardiovascular disease and protection is a subject of continued debate. Recent research findings have modified some of our previous assumptions in this area of medicine. Understanding the relative value of HDL-raising therapy is an integral component of a cardiovascular clinician's therapeutic repertoire.
English Version »
French Version »



Stroke Prevention in Atrial Fibrillation

Date: August 12, 2011
Faculty: Dr. Stuart Connelly, Dr. Paul Dorian, Dr. John Eikelboom

Assessment of stroke risk and stroke prevention remain the first priority in the management of patients with atrial fibrillation. Given the introduction of new anticoagulants into the marketplace, the topic of stroke prevention plays a major part of the 2010 Canadian Cardiovascular Society's AF Guidelines. A stellar faculty discuss this important topic. Read More »



Editors




Disclaimer:

Leading Edge is published by CCRN. #301-3 Conestoga Drive, Brampton, ON L6Z 4N5

No part of this publication may be reproduced, in whole or in part, without the written permission of the publishers. Views expressed are those of the participants and do not necessarily reflect those of the publisher or the sponsor. Any therapies mentioned in these publications should be used in accordance with the recognized prescribing information in Canada. No claims or endorsements are made for any products, uses or doses presently under investigation. Canadian Cardiovascular Research Network does not assume liability for content.